Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-10-27 Purchase |
2020-10-29 5:01 pm |
Foghorn Therapeutics Inc. | FHTX | DECICCO CARL Chief Scientific Officer |
5,500 | $16 | $88,000 | 258,397 (Direct) |
View |
| 2020-10-27 Purchase |
2020-10-29 4:58 pm |
Foghorn Therapeutics Inc. | FHTX | Flagship Ventures Fund V General Partner LLC Flagship Ventures Opportunities Fund I General Partner LLC Flagship Pioneering Special Opportunities Fund II General Partner LLC Flagship Ventures Fund V L.P. Flagship Ventures Opportunities Fund I L.P. Flagship Pioneering Special Opportunities Fund II L.P. Flagship Pioneering Inc. AFEYAN NOUBAR 10% Owner |
150,000 | $16 | $2,400,000 | 1,851,801 (Indirect) |
View |
| 2020-10-27 Purchase |
2020-10-28 06:02 am |
Foghorn Therapeutics Inc. | FHTX | Abu Dhabi Investment Authority Platinum International Investment Holding RSC Ltd Platinum Falcon B 2018 RSC Ltd Former 10% Owner |
150,000 | $16 | $2,400,000 | 1,231,081 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-05-25 Exercise |
2022-05-27 4:10 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | Bellon Steven F. Chief Scientific Officer |
3,717 | $3.72 | 175,673 (Direct) |
View |
| 2022-05-25 Exercise |
2022-05-27 4:10 pm |
N/A 2028-01-30 |
Foghorn Therapeutics Inc. | FHTX | Bellon Steven F. Chief Scientific Officer |
4,392 | $0 | 175,673 (Direct) |
View |
| 2022-05-25 Exercise |
2022-05-27 4:10 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | Bellon Steven F. Chief Scientific Officer |
675 | $0.73 | 175,673 (Direct) |
View |
Ownership |
2022-02-24 7:25 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | Cavalie Fanny Chief Strategy/Bus Ops Officer |
0 | $0 | 337,161 (Direct) |
View |
| 2022-01-26 Option Award |
2022-01-28 4:27 pm |
N/A 2032-01-25 |
Foghorn Therapeutics Inc. | FHTX | Agresta Samuel Chief Medical Officer |
125,000 | $0 | 125,000 (Direct) |
View |
| 2022-01-26 Option Award |
2022-01-28 4:27 pm |
N/A 2032-01-25 |
Foghorn Therapeutics Inc. | FHTX | Bellon Steven F. Chief Scientific Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2022-01-26 Option Award |
2022-01-28 4:26 pm |
N/A 2032-01-25 |
Foghorn Therapeutics Inc. | FHTX | LaCascia Michael Chief Legal Officer |
135,000 | $0 | 135,000 (Direct) |
View |
| 2022-01-26 Option Award |
2022-01-28 4:26 pm |
N/A 2032-01-25 |
Foghorn Therapeutics Inc. | FHTX | Reine Allan Chief Financial Officer |
135,000 | $0 | 135,000 (Direct) |
View |
| 2022-01-26 Option Award |
2022-01-28 4:26 pm |
N/A 2032-01-25 |
Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer |
440,000 | $0 | 911,704 (Direct) |
View |
Ownership |
2022-01-11 4:03 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | Bellon Steven F. Chief Scientific Officer |
0 | $0 | 320,267 (Direct) |
View |
| 2021-12-14 Gift |
2021-12-16 7:20 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | KADOCH CIGALL Director 10% Owner |
333,333 | $0 | 3,624,379 (Direct) |
View |
| 2021-12-09 Exercise |
2021-12-13 8:37 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | DECICCO CARL Chief Scientific Officer |
104,310 | $3.72 | 583,551 (Direct) |
View |
| 2021-12-09 Exercise |
2021-12-13 8:37 pm |
N/A 2029-02-20 |
Foghorn Therapeutics Inc. | FHTX | DECICCO CARL Chief Scientific Officer |
104,310 | $0 | 583,551 (Direct) |
View |
| 2021-08-20 Exercise |
2021-08-23 5:01 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer |
23,000 | $0.54 | 930,629 (Direct) |
View |
| 2021-08-20 Exercise |
2021-08-23 5:01 pm |
N/A 2027-05-29 |
Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer |
23,000 | $0 | 930,629 (Direct) |
View |
| 2021-08-09 Exercise |
2021-08-11 4:14 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | Reine Allan Chief Financial Officer |
26,892 | $3.72 | 311,296 (Direct) |
View |
| 2021-08-09 Exercise |
2021-08-11 4:14 pm |
N/A 2029-09-16 |
Foghorn Therapeutics Inc. | FHTX | Reine Allan Chief Financial Officer |
26,892 | $0 | 311,296 (Direct) |
View |
| 2021-07-13 Option Award |
2021-07-14 4:54 pm |
2022-07-13 2031-07-12 |
Foghorn Therapeutics Inc. | FHTX | Mendelsohn Michael Director |
12,530 | $0 | 12,530 (Direct) |
View |
| 2021-07-13 Option Award |
2021-07-14 4:53 pm |
2022-07-13 2031-07-12 |
Foghorn Therapeutics Inc. | FHTX | Koppel Adam Director |
12,530 | $0 | 12,530 (Direct) |
View |
| 2021-07-13 Option Award |
2021-07-14 4:53 pm |
2022-07-13 2031-07-12 |
Foghorn Therapeutics Inc. | FHTX | KADOCH CIGALL Director 10% Owner |
12,530 | $0 | 12,530 (Direct) |
View |
| 2021-07-13 Option Award |
2021-07-14 4:53 pm |
2022-07-13 2031-07-12 |
Foghorn Therapeutics Inc. | FHTX | GILL SIMBA Director |
12,530 | $0 | 12,530 (Direct) |
View |
| 2021-07-13 Option Award |
2021-07-14 4:52 pm |
2022-07-13 2031-07-12 |
Foghorn Therapeutics Inc. | FHTX | Cole Douglas G. Director |
12,530 | $0 | 12,530 (Direct) |
View |
| 2021-07-13 Option Award |
2021-07-14 4:52 pm |
2022-07-13 2031-07-12 |
Foghorn Therapeutics Inc. | FHTX | Biller Scott Director |
12,530 | $0 | 12,530 (Direct) |
View |
| 2021-06-23 Option Award |
2021-06-24 4:58 pm |
N/A 2031-06-22 |
Foghorn Therapeutics Inc. | FHTX | SMITH IAN F Director |
12,530 | $0 | 12,530 (Direct) |
View |
| 2021-04-27 Option Award |
2021-04-29 5:01 pm |
N/A 2031-04-26 |
Foghorn Therapeutics Inc. | FHTX | SMITH IAN F Director |
25,060 | $11.5 | 25,060 (Direct) |
View |
Ownership |
2021-04-29 4:57 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | SMITH IAN F Director |
0 | $0 | 96,396 (Direct) |
View |
| 2021-01-28 Option Award |
2021-02-01 9:31 pm |
N/A 2031-01-27 |
Foghorn Therapeutics Inc. | FHTX | DECICCO CARL Chief Scientific Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-01-28 Option Award |
2021-02-01 9:26 pm |
N/A 2031-01-27 |
Foghorn Therapeutics Inc. | FHTX | Agresta Samuel Chief Medical Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-01-28 Option Award |
2021-02-01 9:26 pm |
N/A 2031-01-27 |
Foghorn Therapeutics Inc. | FHTX | Reine Allan Chief Financial Officer |
120,000 | $0 | 120,000 (Direct) |
View |
| 2021-01-28 Option Award |
2021-02-01 9:23 pm |
N/A 2031-01-27 |
Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN See Remarks |
300,000 | $0 | 300,000 (Direct) |
View |
| 2020-11-17 Option Award |
2020-11-18 8:18 pm |
N/A 2030-11-16 |
Foghorn Therapeutics Inc. | FHTX | LaCascia Michael Chief Legal Officer |
162,162 | $0 | 162,162 (Direct) |
View |
Ownership |
2020-11-13 5:52 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | Bellon Steven F. See Remarks |
0 | $0 | 270,267 (Direct) |
View |
| 2020-10-27 Conversion |
2020-10-29 4:59 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN See Remarks |
50,450 | $0 | 25,225 (Indirect) |
View |
| 2020-10-27 Conversion |
2020-10-29 4:58 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | Flagship Ventures Fund V General Partner LLC Flagship Ventures Opportunities Fund I General Partner LLC Flagship Pioneering Special Opportunities Fund II General Partner LLC Flagship Ventures Fund V L.P. Flagship Ventures Opportunities Fund I L.P. Flagship Pioneering Special Opportunities Fund II L.P. Flagship Pioneering Inc. AFEYAN NOUBAR 10% Owner |
35,693,745 | $0 | 1,851,801 (Indirect) |
View |
| 2020-10-27 Conversion |
2020-10-28 06:02 am |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | Abu Dhabi Investment Authority Platinum International Investment Holding RSC Ltd Platinum Falcon B 2018 RSC Ltd Former 10% Owner |
3,081,082 | $0 | 1,231,081 (Direct) |
View |
Ownership |
2020-10-22 9:05 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | Flagship Ventures Fund V General Partner LLC Flagship Ventures Opportunities Fund I General Partner LLC Flagship Pioneering Special Opportunities Fund II General Partner LLC Flagship Ventures Fund V L.P. Flagship Ventures Opportunities Fund I L.P. Flagship Pioneering Special Opportunities Fund II L.P. Flagship Pioneering Inc. AFEYAN NOUBAR 10% Owner |
0 | $0 | 12,524,120 (Indirect) |
View |
Ownership |
2020-10-22 9:04 pm |
N/A 2027-04-04 |
Foghorn Therapeutics Inc. | FHTX | Mendelsohn Michael Director |
0 | $0 | 94,594 (Direct) |
View |
Ownership |
2020-10-22 9:03 pm |
N/A 2028-01-30 |
Foghorn Therapeutics Inc. | FHTX | Koppel Adam Director |
0 | $0 | 94,594 (Direct) |
View |
Ownership |
2020-10-22 8:59 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | KADOCH CIGALL Director 10% Owner |
0 | $0 | 3,957,712 (Direct) |
View |
Ownership |
2020-10-22 8:58 pm |
N/A 2027-11-01 |
Foghorn Therapeutics Inc. | FHTX | GILL SIMBA Director |
0 | $0 | 189,188 (Direct) |
View |
Ownership |
2020-10-22 8:57 pm |
N/A 2030-06-04 |
Foghorn Therapeutics Inc. | FHTX | Biller Scott Director |
0 | $0 | 94,594 (Direct) |
View |
Ownership |
2020-10-22 8:56 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | Baselga Jose Director |
0 | $0 | 94,594 (Direct) |
View |